Dr. Fajgenbaum maintains that patients should focus on whether there is good data to support a drug's efficacy rather than focusing on the source of the drug.

“I think try to get less caught up on, you know, is it from a drug company or, you know, what's the source of it? But I think just really just just actually track like, you know, is there good data here?”